136 related articles for article (PubMed ID: 29141888)
21. Origin and production of inflammatory perivascular macrophages in pulmonary hypertension.
Florentin J; Dutta P
Cytokine; 2017 Dec; 100():11-15. PubMed ID: 28855075
[TBL] [Abstract][Full Text] [Related]
22. Soluble guanylate cyclase stimulator riociguat and phosphodiesterase 5 inhibitor sildenafil ameliorate pulmonary hypertension due to left heart disease in mice.
Pradhan K; Sydykov A; Tian X; Mamazhakypov A; Neupane B; Luitel H; Weissmann N; Seeger W; Grimminger F; Kretschmer A; Stasch JP; Ghofrani HA; Schermuly RT
Int J Cardiol; 2016 Aug; 216():85-91. PubMed ID: 27140341
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of cGMP phosphodiesterase 5 suppresses matrix metalloproteinase-2 production in pulmonary artery smooth muscles cells.
Sun XZ; Li ZF; Liu Y; Fang P; Li MX
Clin Exp Pharmacol Physiol; 2010 Mar; 37(3):362-7. PubMed ID: 19793106
[TBL] [Abstract][Full Text] [Related]
24. A Time- and Compartment-Specific Activation of Lung Macrophages in Hypoxic Pulmonary Hypertension.
Pugliese SC; Kumar S; Janssen WJ; Graham BB; Frid MG; Riddle SR; El Kasmi KC; Stenmark KR
J Immunol; 2017 Jun; 198(12):4802-4812. PubMed ID: 28500078
[TBL] [Abstract][Full Text] [Related]
25. Decreased numbers of T-lymphocytes and predominance of recently recruited macrophages in the walls of peripheral pulmonary arteries from 26 patients with pulmonary hypertension secondary to congenital cardiac shunts.
Pinto RF; Higuchi Mde L; Aiello VD
Cardiovasc Pathol; 2004; 13(5):268-75. PubMed ID: 15358341
[TBL] [Abstract][Full Text] [Related]
26. Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury.
Ladha F; Bonnet S; Eaton F; Hashimoto K; Korbutt G; Thébaud B
Am J Respir Crit Care Med; 2005 Sep; 172(6):750-6. PubMed ID: 15947285
[TBL] [Abstract][Full Text] [Related]
27. Vardenafil reduces macrophage pro-inflammatory overresponses in cystic fibrosis through PDE5- and CFTR-dependent mechanisms.
Noel S; Panin N; Beka M; Dhooghe B; Huaux F; Leal T
Clin Sci (Lond); 2017 Jun; 131(11):1107-1121. PubMed ID: 28196856
[TBL] [Abstract][Full Text] [Related]
28. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
[TBL] [Abstract][Full Text] [Related]
29. Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling.
Taraseviciene-Stewart L; Nicolls MR; Kraskauskas D; Scerbavicius R; Burns N; Cool C; Wood K; Parr JE; Boackle SA; Voelkel NF
Am J Respir Crit Care Med; 2007 Jun; 175(12):1280-9. PubMed ID: 17413127
[TBL] [Abstract][Full Text] [Related]
30. Key inflammatory pathways underlying vascular remodeling in pulmonary hypertension.
Berghausen EM; Feik L; Zierden M; Vantler M; Rosenkranz S
Herz; 2019 Apr; 44(2):130-137. PubMed ID: 30847510
[TBL] [Abstract][Full Text] [Related]
31. NF-κB mediated miR-130a modulation in lung microvascular cell remodeling: Implication in pulmonary hypertension.
Li L; Kim IK; Chiasson V; Chatterjee P; Gupta S
Exp Cell Res; 2017 Oct; 359(1):235-242. PubMed ID: 28755990
[TBL] [Abstract][Full Text] [Related]
32. A nuclear factor-kappaB inhibitor pyrrolidine dithiocarbamate ameliorates pulmonary hypertension in rats.
Sawada H; Mitani Y; Maruyama J; Jiang BH; Ikeyama Y; Dida FA; Yamamoto H; Imanaka-Yoshida K; Shimpo H; Mizoguchi A; Maruyama K; Komada Y
Chest; 2007 Oct; 132(4):1265-74. PubMed ID: 17934115
[TBL] [Abstract][Full Text] [Related]
33. Extracellular Cyclophilin A, Especially Acetylated, Causes Pulmonary Hypertension by Stimulating Endothelial Apoptosis, Redox Stress, and Inflammation.
Xue C; Sowden M; Berk BC
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1138-1146. PubMed ID: 28450293
[TBL] [Abstract][Full Text] [Related]
34. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.
Ghofrani HA; Voswinckel R; Reichenberger F; Olschewski H; Haredza P; Karadaş B; Schermuly RT; Weissmann N; Seeger W; Grimminger F
J Am Coll Cardiol; 2004 Oct; 44(7):1488-96. PubMed ID: 15464333
[TBL] [Abstract][Full Text] [Related]
35. Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis.
Avouac J; Guignabert C; Hoffmann-Vold AM; Ruiz B; Dorfmuller P; Pezet S; Amar O; Tu L; Van Wassenhove J; Sadoine J; Launay D; Elhai M; Cauvet A; Subramaniam A; Resnick R; Hachulla E; Molberg Ø; Kahan A; Humbert M; Allanore Y
Arthritis Rheumatol; 2017 Nov; 69(11):2209-2221. PubMed ID: 28805015
[TBL] [Abstract][Full Text] [Related]
36. Tadalafil induces antiproliferation, apoptosis, and phosphodiesterase type 5 downregulation in idiopathic pulmonary arterial hypertension in vitro.
Yamamura A; Fujitomi E; Ohara N; Tsukamoto K; Sato M; Yamamura H
Eur J Pharmacol; 2017 Sep; 810():44-50. PubMed ID: 28603047
[TBL] [Abstract][Full Text] [Related]
37. Lewis Lung Cancer Cells Promote SIGNR1(CD209b)-Mediated Macrophages Polarization Induced by IL-4 to Facilitate Immune Evasion.
Yan X; Li W; Pan L; Fu E; Xie Y; Chen M; Mu D
J Cell Biochem; 2016 May; 117(5):1158-66. PubMed ID: 26447454
[TBL] [Abstract][Full Text] [Related]
38. Salusin-β contributes to vascular inflammation associated with pulmonary arterial hypertension in rats.
Xu T; Zhang Z; Liu T; Zhang W; Liu J; Wang W; Wang J
J Thorac Cardiovasc Surg; 2016 Oct; 152(4):1177-87. PubMed ID: 27353339
[TBL] [Abstract][Full Text] [Related]
39. Inflammation, immunological reaction and role of infection in pulmonary hypertension.
Pullamsetti SS; Savai R; Janssen W; Dahal BK; Seeger W; Grimminger F; Ghofrani HA; Weissmann N; Schermuly RT
Clin Microbiol Infect; 2011 Jan; 17(1):7-14. PubMed ID: 20545963
[TBL] [Abstract][Full Text] [Related]
40. Nur77 downregulation triggers pulmonary artery smooth muscle cell proliferation and migration in mice with hypoxic pulmonary hypertension via the Axin2-β-catenin signaling pathway.
Nie X; Tan J; Dai Y; Mao W; Chen Y; Qin G; Li G; Shen C; Zhao J; Chen J
Vascul Pharmacol; 2016 Dec; 87():230-241. PubMed ID: 27871853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
